News › Industry News, News

Revance Announces U.S. Distribution Deal for Dermal Fillers from Teoxane SA

January 13, 2020

Revance Therapeutics, Inc., a biotechnology company searching for new innovations in neuromodulators for aesthetic and therapeutic indications, has announced the signing of a U.S. distribution agreement with Teoxane SA, making Revance the exclusive commercialization partner of the Swiss company’s Resilient Hyaluronic Acid (RHA) technology.
Read more from Revance >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • SkinMedica launches Regenerative Science Advisory Board
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Advisory Committee to Review Seven Peptides for Potential Use in Compounding
Advertisement